Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Mast cells: a pivotal role in pulmonary fibrosis.

Veerappan A, O'Connor NJ, Brazin J, Reid AC, Jung A, McGee D, Summers B, Branch-Elliman D, Stiles B, Worgall S, Kaner RJ, Silver RB.

DNA Cell Biol. 2013 Apr;32(4):206-18. doi: 10.1089/dna.2013.2005.

2.

Latent transforming growth factor-beta-binding protein-4 regulates transforming growth factor-beta1 bioavailability for activation by fibrogenic lung fibroblasts in response to bleomycin.

Zhou Y, Koli K, Hagood JS, Miao M, Mavalli M, Rifkin DB, Murphy-Ullrich JE.

Am J Pathol. 2009 Jan;174(1):21-33. doi: 10.2353/ajpath.2009.080620. Epub 2008 Dec 4.

4.

Animal model of sclerotic skin. II. Bleomycin induced scleroderma in genetically mast cell deficient WBB6F1-W/W(V) mice.

Yamamoto T, Takahashi Y, Takagawa S, Katayama I, Nishioka K.

J Rheumatol. 1999 Dec;26(12):2628-34.

PMID:
10606374
5.

Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice.

Tabata C, Tabata R, Kadokawa Y, Hisamori S, Takahashi M, Mishima M, Nakano T, Kubo H.

J Immunol. 2007 Jul 1;179(1):708-14.

6.

The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice.

Tabata C, Tabata R, Nakano T.

Clin Exp Immunol. 2010 Dec;162(3):560-7. doi: 10.1111/j.1365-2249.2010.04257.x. Epub 2010 Sep 15.

7.

Protective role of gambogic acid in experimental pulmonary fibrosis in vitro and in vivo.

Qu Y, Zhang G, Ji Y, Zhua H, Lv C, Jiang W.

Phytomedicine. 2016 Apr 15;23(4):350-8. doi: 10.1016/j.phymed.2016.01.011. Epub 2016 Feb 9.

PMID:
27002405
9.
10.

Chronic alcohol ingestion primes the lung for bleomycin-induced fibrosis in mice.

Sueblinvong V, Kerchberger VE, Saghafi R, Mills ST, Fan X, Guidot DM.

Alcohol Clin Exp Res. 2014 Feb;38(2):336-43. doi: 10.1111/acer.12232. Epub 2013 Aug 16.

11.

Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.

Zhou Y, Yang J, Sun GY, Liu T, Duan JX, Zhou HF, Lee KS, Hammock BD, Fang X, Jiang JX, Guan CX.

Cell Tissue Res. 2016 Feb;363(2):399-409. doi: 10.1007/s00441-015-2262-0. Epub 2015 Aug 28. Erratum in: Cell Tissue Res. 2016 Jun;364(3):675.

12.

Involvement of mast cell chymase in bleomycin-induced pulmonary fibrosis in mice.

Tomimori Y, Muto T, Saito K, Tanaka T, Maruoka H, Sumida M, Fukami H, Fukuda Y.

Eur J Pharmacol. 2003 Oct 8;478(2-3):179-85.

PMID:
14575803
13.

Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.

Wu YH, Li XW, Li WQ, Li XH, Li YJ, Hu GY, Liu ZQ, Li D.

Eur J Pharmacol. 2016 Feb 15;773:42-50. doi: 10.1016/j.ejphar.2016.01.006. Epub 2016 Jan 25.

PMID:
26821114
14.

VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.

Ou XM, Li WC, Liu DS, Li YP, Wen FQ, Feng YL, Zhang SF, Huang XY, Wang T, Wang K, Wang X, Chen L.

Int Immunopharmacol. 2009 Jan;9(1):70-9. doi: 10.1016/j.intimp.2008.10.002. Epub 2008 Oct 29.

PMID:
18976720
15.

Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.

Gou S, Zhu T, Wang W, Xiao M, Wang XC, Chen ZH.

Int Immunopharmacol. 2014 Oct;22(2):498-504. doi: 10.1016/j.intimp.2014.07.010. Epub 2014 Aug 10.

PMID:
25111852
16.

The anti-fibrotic effects of microRNA-153 by targeting TGFBR-2 in pulmonary fibrosis.

Liang C, Li X, Zhang L, Cui D, Quan X, Yang W.

Exp Mol Pathol. 2015 Oct;99(2):279-85. doi: 10.1016/j.yexmp.2015.07.011. Epub 2015 Jul 26.

PMID:
26216407
17.

Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice.

Liu T, Chung MJ, Ullenbruch M, Yu H, Jin H, Hu B, Choi YY, Ishikawa F, Phan SH.

J Clin Invest. 2007 Dec;117(12):3800-9.

18.

Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model.

Veerappan A, Reid AC, O'Connor N, Mora R, Brazin JA, Estephan R, Kameue T, Chen J, Felsen D, Seshan SV, Poppas DP, Maack T, Silver RB.

Am J Physiol Renal Physiol. 2012 Jan 1;302(1):F192-204. doi: 10.1152/ajprenal.00562.2010. Epub 2011 Sep 28.

19.

Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.

Meng Y, Yu CH, Li W, Li T, Luo W, Huang S, Wu PS, Cai SX, Li X.

Am J Respir Cell Mol Biol. 2014 Apr;50(4):723-36. doi: 10.1165/rcmb.2012-0451OC.

PMID:
24168260
20.

Opposing regulatory roles of complement factor 5 in the development of bleomycin-induced pulmonary fibrosis.

Addis-Lieser E, Köhl J, Chiaramonte MG.

J Immunol. 2005 Aug 1;175(3):1894-902.

Supplemental Content

Support Center